Efficacy of topical antifungal drugs in different dermatomycoses: A systematic review with meta-analysis

Revista da Associacao Medica Brasileira

Volumn 58, Issue 3, 2012, Pages 308-318

  Rotta, Inajara ^a   Otuki, Michel Fleith ^b   Sanches, Andréia Cristina Conegero ^c   Correr, Cassyano Januário ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b STATE UNIVERSITY OF PONTA GROSSA   (Brazil)

^c UNIVERSIDADE ESTADUAL DO OESTE DO PARANÁ   (Brazil)

Author keywords

Antimycotic drugs; Dermatomycoses; Meta analysis; Topical administration

Indexed keywords

ANTIFUNGAL AGENT;

HUMAN; INTRADERMAL DRUG ADMINISTRATION; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SKIN CANDIDIASIS; TINEA; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ANTIFUNGAL AGENTS; CANDIDIASIS, CUTANEOUS; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TINEA; TREATMENT OUTCOME;

EID: 84864829229     PISSN: 01044230     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0104-4230(12)70200-2     Document Type: Article

References (64)

1. Borgers M, Degreef H, Cauwenbergh G. Fungal infections of the skin: infection process and antimycotic therapy. Curr Drug Targets. 2005;6(8):849-62.
2. Charles AJ. Superficial cutaneous fungal infections in tropical countries. Dermatol Ther. 2009;22(6):550-9.
3. Garber G. An overview of fungal infections. Drugs. 2001;61(Suppl 1):1-12.
4. Gupta AK, Einarson TR, Summerbell RC, Shear NH. An overview of topical antifungal therapy in dermatomycoses. A North American perspective. Drugs. 1998;55(5):645-74.
5. Hainer BL. Dermatophyte infections. Am Fam Physician. 2003;67(1):101-8.
6. Severo LC, Londero AT. Tratado de infectologia. São Paulo: Atheneu, 2002.
7. Gupta AK, Cooper EA. Update in antifungal therapy of dermatophytosis. Mycopathologia. 2008;166(5-6):353-67.
8. Meis JF, Verweij PE. Current management of fungal infections. Drugs. 2001;61(Suppl 1):13-25.
9. Brasil. Agência Nacional de Vigilância Sanitária (ANVISA). Resolução da Diretoria Colegiada (RDC) no 138 de 29 de maio de 2003. Dispõe sobre o enquadramento na categoria de venda de medicamentos. Diário Oficial da República Federativa do Brasil. 02 jun 2003.
10. Crawford F, Hollis S. Topical treatments for fungal infections of the skin and nails of the foot. Cochrane Database Syst Rev. 2007(3):1-157.
11. Hart R, Bell-Syer SE, Crawford F, Torgerson DJ, Young P, Russell I. Systematic review of topical treatments for fungal infections of the skin and nails of the feet. BMJ. 1999;319(7202):79-82.
12. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.2 [atualizado set. 2009]. 2011.
13. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1-12.
14. Oxford University. Centre for Evidence Based Medicine (CEBM). [cited Jun 2011]. Oxford: Oxford University; 2011. Avaliable from: http://www.cebm.net/.
15. Astorga E, Cordero CN, de Espinoza ZD, Rojas RF, Zaias N, Sefton J. Naftifine cream 1% in cutaneous candidiasis. Curr Ther Res Clin Exp. 1989;46(6):1106-1109.
16. Bagatell FK, Bart BJ, Cole GW, Drake LA, Ellis CN, Arbor A, et al. Naftifine gel in the treatment of tinea pedis: two double-blind, multicenter studies. Cutis. 1991; 48 (1): 85-88.
17. Berman B, Ellis C, Leyden J, Lowe N, Savin R, Shupack J, et al. Efficacy of a 1-week, twice-daily regimen of terbinafine 1% cream in the treatment of interdigital tinea pedis. Results of placebo-controlled, double-blind, multicenter trials. J Am Acad Dermatol. 1992;26 (6):956-960.
18. Budimulja U, Bramono K, Urip KS, Basuki S, Widodo G, Rapatz G, et al. Once daily treatment with terbinafine 1% cream (Lamisil) for one week is effective in the treatment of tinea corporis and cruris. A placebo-controlled study. Mycoses. 2001;44(7-8):300-306.
19. Cullen SI. Cutaneous candidiasis: Treatment with miconazole nitrate. Cutis. 1977;19(1):126-129.
20. Cullen SI, Rex IH, Thorne EG. A comparison of a new antifungal agent, 1 percent econazole nitrate (Spectazole(registered trademark) cream versus 1 percent clotrimazole cream in the treatment of intertriginous candidosis. Curr Ther Res Clin Exp. 1984;35 (4):606-609.
21. Daily AD, Kramer KJ, Rex IH, Thorne EG. Econazole nitrate (Spectazole) cream, 1 percent: a topical agent for the treatment of tinea pedis. Cutis. 1985;35(3):278-280.
22. Duncan WC. Tinea pedis: treatment with topical miconazole. Cutis. 1975;16(4):647-649.
23. Ellis CN, Gammon WR, Goldfarb MT, Griffin TB, Jegasothy BV, Kamm AR, et al. A placebo-controlled evaluation of once-daily versus twice-daily oxiconazole nitrate (1%) cream in the treatment of tinea pedis Curr Ther Res Clin Exp. 1989;46(2):269-276.
24. Evans EGV, James IGV, Joshipura RC. Two-week treatment of tinea pedis with terbinafine (Lamisil) 1% cream: A placebo controlled study. J Dermatolog Treat. 1991;2(3):95-97.
25. Evans EGV, Shah JM, Joshipura RC. One-week treatment of tinea corporis and tinea cruris with terbinafine (Lamisil) 1% cream: A placebo-controlled study. J Dermatolog Treat. 1992;3(4):181-184.
26. Faergemann J, Hersle K, Nordin P. Pityriasis versicolor: clinical experience with Lamisil cream and Lamisil DermGel. Dermatology. 1997;194(Suppl.1):19-21.
27. Gentles JC, Jones GR, Roberts DT. Efficacy of miconazole in the topical treatment of tinea pedis in sportsmen. Br J Dermatol. 1975;93(1):79-84.
28. Greer DL, Jolly HW Jr. Treatment of tinea cruris with topical terbinafine. J Am Acad Dermatol. 1990;23(4):800-804.
29. Hollmen KA, Kinnunen T, Kiistala U, Väänänen A, Saarelainen IO, De CC, et al. Efficacy and tolerability of terbinafine 1% emulsion gel in patients with tinea pedis. J Eur Acad Dermatol Venereol. 2002;16(1):87-88.
30. James IG, Loria-Kanza Y, Jones TC. Short-duration topical treatment of tinea pedis using terbinafine emulsion gel: results of a dose-ranging clinical trial. J Dermatolog Treat. 2007;18(3):163-168.
31. Korting HC, Tietz HJ, Bräutigam M, Mayser P, Rapatz G, Paul C. One week terbinafine 1% cream (Lamisil) once daily is effective in the treatment of interdigital tinea pedis: a vehicle controlled study. LAS-INT-06 Study Group. Med Mycol. 2001;39(4):335-340.
32. Lalosević J, Rojas R, Astorga E, Gip L. Bifonazole cream in the treatment of superficial candidosis. A double-blind comparative study. Dermatologica. 1984; 169 (sup.1): 99-106.
33. Lebwohl M, Elewski B, Eisen D, Savin RC. Efficacy and safety of terbinafine 1% solution in the treatment of interdigital tinea pedis and tinea corporis or tinea cruris. Cutis. 2001;67(3):261-266.
34. Millikan LE. Efficacy and tolerability of topical terbinafine in the treatment of tinea cruris. J Am Acad Dermatol. 1990;23(4):795-799.
35. Montoya F, Vélez H. Evaluación terapéutica de naftifine en pacientes con dermatofitosis y pitiriasis versicolor. Acta Med Colomb. 1985;10(2):79-94.
36. Mora RG, Greer DL. Comparative efficacy and tolerance of 1% bifonazole cream and bifonazole cream vehicle in patients with tinea versicolor. Dermatologica. 1984;169(Suppl.1):87-92.
37. Ortiz P. Topical miconazole nitrate therapy in tinea pedis and tinea versicolor. Clin Ther. 1978;1(6):444-50.
38. Ortonne JP, Korting HC, Viguié-Vallanet C, Larnier C, Savaluny E. Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete's foot): a randomized, double-blind, placebo-controlled study. J Eur Acad Dermatol Venereol. 2006;20(10):1307-1313.
39. Quiñones CA. Tinea versicolor: new topical treatments. Cutis. 1980;25(4):386-388.
40. Savin RC, Horwitz SN. Double-blind comparison of 2% ketoconazole cream and placebo in the treatment of tinea versicolor. J Am Acad Dermatol. 1986;15(3):500-503.
41. Savin RC. Treatment of chronic tinea pedis (athlete's foot type) with topical terbinafine. J Am Acad Dermatol. 1990;23(4):786-789.
42. Savin R, Eisen D, Fradin MS, Lebwohl M. Tinea versicolor treated with terbinafine 1% solution. Int J Dermatol. 1999;38(11):863-865.
43. Savin R, Jorizzo J. The safety and efficacy of sertaconazole nitrate cream 2% for tinea pedis. Cutis. 2006;78(4):268-274.
44. Segal R, Kricheli D, Zukrov B, David M. Treatment of pityriasis versicolor with bifonazole shampoo: A randomized double-blind study. J Dermatolog Treat. 1999;10(3):185-188.
45. Smith EB, Graham JL, Ulrich JA. Topical clotrimazole in tinea pedis. South Med J. 1977;70(1):47-48.
46. Smith EB, Noppakun N, Newton RC. A clinical trial of topical terbinafine (a new allylamine antifungal) in the treatment of tinea pedis. J Am Acad Dermatol. 1990;23(4):790-794.
47. Syed TA, Hadi SM, Qureshi ZA, Ali SM, Ahmad SA. Butenafine 1% versus terbinafine 1% in cream for the treatment of tinea pedis. A placebo-controlled, double-blind, comparative study. Clin Drug Invest. 2000;19(6):393-397.
48. Van Heerden JS, Vismer HF. Tinea corporis/cruris: new treatment options. Dermatology. 1997;194(Suppl.1):14-18.
49. Vermeer BJ, Staats CC. The efficacy of a topical application of terbinafine 1% solution in subjects with pityriasis versicolor: a placebo-controlled study. Dermatology. 1997;194(Suppl.1):22-4.
50. Vicik GJ, Mendiones M, Quinones CA, Thorne EG. A new treatment for tinea versicolor using econazole nitrate 1.0 percent cream once a day. Cutis. 1984;33(6):570-571.
51. Zaias N, Astorga E, Cordero CN, Day RM, de Espinoza ZD, DeGryse R, et al. Naftifine cream in the treatment of cutaneous candidiasis. Cutis. 1988;42(3):238-240.
52. Ablon G, Rosen T, Spedale J. Comparative efficacy of naftifine, oxiconazole, and terbinafine in short-term treatment of tinea pedis. Int J Dermatol. 1996;35(8):591-3.
53. Aste N, Pau M, Pinna AL, Colombo MD, Biggio P. Clinical efficacy and tolerability of terbinafine in patients with pityriasis versicolor. Mycoses. 1991;34(7-8):353-7.
54. Bergstresser PR, Elewski B, Hanifin J, Lesher J, Savin R, Shupack J, et al. Topical terbinafine and clotrimazole in interdigital tinea pedis: a multicenter comparison of cure and relapse rates with 1-and 4-week treatment regimens. J Am Acad Dermatol. 1993;28(4):648-651.
55. Budimulja U. Terbinafine 1% cream vs. bifonazole 1% cream in the treatment of tinea cruris. Int J Dermatol. 1998;37(11):871-873.
56. Evans EG, Dodman B, Williamson DM, Brown GJ, Bowen RG. Comparison of terbinafine and clotrimazole in treating tinea pedis. BMJ. 1993;307(6905):645-7.
57. Irvine CA, Kenilworth NJ. Naftifine cream 1% versus clotrimazole cream 1% in the treatment of tinea pedis. Naftifine Podiatric Study Group. J Am Podiatr Med Assoc. 1990;80(6):314-318.
58. Leenutaphong V, Niumpradit N, Tangwiwat S, Sritaveesuwan R, Muanprasat C. Double-blind study of the efficacy of 1 week topical terbinafine cream compared to 4 weeks miconazole cream in patients with tinea pedis. J Med Assoc Thai. 1999;82(10):1006-1010.
59. Millikan LE, Galen WK, Gewirtzman GB, Horwitz SN, Landow RK, Nesbitt LT Jr, et al. Naftifine cream 1% versus econazole cream 1% in the treatment of tinea cruris and tinea corporis. J Am Acad Dermatol. 1988;18(1):52-56.
60. Sanchez-Carazo JL, Fuente C, Oliver V, Umbert P. A comparative study of terbinafine. Actas Dermo-Sifiliograficas. 1994;85(5):388-394.
61. Schopf R, Hettler O, Bräutigam M, Weidinger G, Kaben U, Mayser P, et al. Efficacy and tolerability of terbinafine 1% topical solution used for 1 week compared with 4 weeks clotrimazole 1% topical solution in the treatment of interdigital tinea pedis: a randomized, double-blind, multi-centre, 8-week clinical trial. Mycoses. 1999;42(5-6):415-20.
62. Smith EB, Wiss K, Hanifin JM, Jordon RE, Rapini RP, Lasser AE, et al. Comparison of once and twice-daily naftifine cream regimens with twice-daily clotrimazole in the treatment of tinea pedis. J Am Acad Dermatol. 1990;22(6):1116-1117.
63. Wahid Z, Butt J, Nishtar R. Multicentre double-blind study of efficacy and safety of terbinafine 1% cream compared with bifonazole 1% cream in patients with tinea pedis moccasin type. J Dermatolog Treat. 1997;8(4):225-227.
64. Crawford F, Harris R, Williams HC. Are placebo-controlled trials of creams for athletes foot still justified? Br J Dermatol. 2008;159(4):773-9.